259 results on '"Clare Allen"'
Search Results
152. Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway
- Author
-
Peter Hoskin, Aslam Sohaib, Louise Dickinson, Hashim U. Ahmed, Shonit Punwani, B. Carey, Jan van der Meulen, Jurgen J. Fütterer, Anwar R. Padhani, Jelle O. Barentsz, Philippe Puech, Mark Emberton, Clare Allen, Bertrand Tombal, Alex Kirkham, Raj Persad, Arnauld Villers, and Stijn W.T.P.J. Heijmink
- Subjects
Male ,In vivo magnetic resonance spectroscopy ,medicine.medical_specialty ,Biopsy ,Urology ,Sensitivity and Specificity ,Prostate cancer ,Breast cancer ,Prostate ,Energy and redox metabolism Aetiology, screening and detection [NCMLS 4] ,medicine ,Humans ,Mammography ,medicine.diagnostic_test ,Cardiovascular diseases [NCEBP 14] ,business.industry ,News and Topics ,Prostatic Neoplasms ,Reproducibility of Results ,Multiparametric MRI ,Cancer ,Magnetic resonance imaging ,medicine.disease ,Magnetic Resonance Imaging ,Radiography ,medicine.anatomical_structure ,Oncology ,Radiology ,business ,Cardiovascular diseases Aetiology, screening and detection [NCEBP 14] - Abstract
Interest in integrating MRI into the prostate (CaP) cancer diagnostic pathway seems to be gaining ground [1]. Multiparametric (mp)MRI combines diffusion-weighted, dynamic contrast enhanced sequences or MR spectroscopy with conventional T2-weighted sequences. This has resulted in accuracy rates for the detection of clinically important CaP that compare favorably with established tests, such as X-ray mammography, for the detection of breast cancer [1,2]. However, its exact clinical utility remains the subject of legitimate professional disagreement. In this commentary, we attempt to highlight the areas in which mpMRI may have a role in improving the diagnosis and management of CaP.
- Published
- 2013
153. MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging
- Author
-
Alex Kirkham, Mathias Winkler, Alex Freeman, Charles Jameson, Caroline M. Moore, Brandon Whitcher, Gareth Ambler, Simon Bott, Anita Mitra, Giulio Gambarota, Nicola L. Robertson, Clare Allen, Mark Emberton, Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes 1 (UR1), and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,Time Factors ,Biopsy ,MESH: Organ Size ,030232 urology & nephrology ,law.invention ,MESH: 5-alpha Reductase Inhibitors ,MESH: Dose-Response Relationship, Drug ,MESH: Magnetic Resonance Imaging ,chemistry.chemical_compound ,Prostate cancer ,MESH: Biopsy ,0302 clinical medicine ,5-alpha Reductase Inhibitors ,Randomized controlled trial ,[INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing ,law ,Prostate ,Pharmacology (medical) ,MESH: Double-Blind Method ,Prospective Studies ,Prospective cohort study ,MESH: Treatment Outcome ,Randomised controlled trial ,medicine.diagnostic_test ,General Medicine ,Organ Size ,MESH: Follow-Up Studies ,3. Good health ,medicine.anatomical_structure ,Treatment Outcome ,030220 oncology & carcinogenesis ,[SDV.IB]Life Sciences [q-bio]/Bioengineering ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,Adult ,medicine.medical_specialty ,Urology ,Placebo ,MESH: Prostate ,MESH: Azasteroids ,03 medical and health sciences ,Magnetic resonance imaging ,Double-Blind Method ,medicine ,Humans ,Gynecology ,MESH: Humans ,Dose-Response Relationship, Drug ,business.industry ,MESH: Time Factors ,Cancer ,Prostatic Neoplasms ,MESH: Adult ,Dutasteride ,medicine.disease ,MESH: Prospective Studies ,MESH: Male ,chemistry ,Azasteroids ,MESH: Prostatic Neoplasms ,business ,Follow-Up Studies - Abstract
International audience; OBJECTIVE: To evaluate the percentage change in volume of prostate cancer, as assessed by T2-weighted MRI, following exposure to dutasteride (Avodart) 0.5mg daily for six months. PATIENTS AND METHODS: MRI in Primary Prostate cancer after Exposure to Dutasteride (MAPPED) is a double-blind, placebo-controlled trial, supported by GlaxoSmithKline (GSK). Men with prostate cancer suitable for active surveillance (low-intermediate risk prostate cancer on biopsy), and a visible lesion on T2-weighted MRI of at least 0.2 cc, were eligible for consideration. Forty-two men were randomised to 6 months of daily dutasteride 0.5mg or placebo. Multi-parametric MRI (mpMRI) scans were performed at baseline, 3 and 6 months. The percentage changes in cancer volume over time will be compared between the dutasteride and placebo groups. Planned analyses will examine the association between tumour volume and characteristics (perfusion and contrast washout) as seen on mpMRI, HistoScan ultrasound and biopsy histopathology in both groups. DISCUSSION: MAPPED is the first randomised controlled trial to use mpMRI to look at the effect of dutasteride on the volume of prostate cancer. If dutasteride is shown to reduce the volume of prostate cancer, it might be considered as an adjunct for men on active surveillance. Analysis of the placebo arm will allow us to comment on the short-term natural variability of the MR appearance in men who are not receiving any treatment. CONCLUSION: MAPPED will evaluate the short-term effect of dutasteride on prostate cancer volume, as assessed by mpMRI, in men undergoing active surveillance for low or intermediate risk prostate cancer. The study completed recruitment in January 2012.
- Published
- 2013
- Full Text
- View/download PDF
154. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: Could standardization lead to improved utilization of imaging within the diagnostic pathway?
- Author
-
Anwar R. Padhani, Jurgen J. Fütterer, Clare Allen, Alex Kirkham, Hashim U. Ahmed, Stijn W.T.P.J. Heijmink, Peter Hoskin, Jelle O. Barentsz, Philippe Puech, Shonit Punwani, Raj Persad, Aslam Sohaib, B. Carey, Mark Emberton, Bertrand Tombal, Arnauld Villers, and Louise Dickinson
- Subjects
Biochemical recurrence ,Diagnostic Imaging ,Male ,Quality Control ,medicine.medical_specialty ,Prostate biopsy ,Biopsy ,Contrast Media ,Medical Oncology ,Cohort Studies ,Prostate cancer ,Prostate ,Energy and redox metabolism Aetiology, screening and detection [NCMLS 4] ,medicine ,Medical imaging ,Humans ,Radiology, Nuclear Medicine and imaging ,Medical physics ,Multiparametric Magnetic Resonance Imaging ,medicine.diagnostic_test ,Cardiovascular diseases [NCEBP 14] ,business.industry ,Cancer ,Prostatic Neoplasms ,Magnetic resonance imaging ,medicine.disease ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,ROC Curve ,Disease Progression ,Radiology ,business ,Cardiovascular diseases Aetiology, screening and detection [NCEBP 14] ,Biomarkers - Abstract
Item does not contain fulltext Multiparametric magnetic resonance imaging (mpMRI) is increasingly being used earlier in the prostate cancer diagnostic pathway in order to detect and localize disease. Its results can be used to help decide on the indication, type, and localization of a prostate biopsy for cancer diagnosis. In addition, mpMRI has the potential to contribute information on the characterization, or aggressiveness, of detected cancers including tumor progression over time. There is considerable variation in the way results of different MRI sequences are reported. We conducted a review of scoring systems that have been used in the detection and characterization of prostate cancer. This revealed that existing scoring and reporting systems differ in purpose, scale, and range. We evaluate these differences in this review. This first step in collating all methods of scoring and reporting mpMRI will ultimately lead to consensus approaches to develop a standardized reporting scheme that can be widely adopted and validated to ensure comparability of research outputs and optimal clinical practice.
- Published
- 2013
- Full Text
- View/download PDF
155. Portable chest radiology in intensive care: A comparison of a new dual characteristic film-screen system (Insight) incorporating a flexible grid with a standard film-screen system
- Author
-
P. Maggs, Clare Allen, R.J.S. Chin, D. Kessel, and G.T. Rottenberg
- Subjects
Male ,medicine.medical_specialty ,Medical staff ,Critical Care ,Radiography ,Radiation Dosage ,law.invention ,law ,Intensive care ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,Chest radiology ,Aged ,Digital radiography ,business.industry ,Equipment Design ,General Medicine ,Middle Aged ,Grid ,Intensive care unit ,Conventional radiography ,Evaluation Studies as Topic ,Female ,Radiography, Thoracic ,Radiology ,business - Abstract
Insight (Insight, Kodak, UK) is a new dual image receptor system which utilizes an asymmetric film screen combination. Conventional radiography was compared with the Insight system, in combination with a cassette incorporating a flexible grid, in fifty patients on the intensive care unit. Radiographs were analysed by intensive care junior medical staff, nursing staff and two groups of radiologists. Insight provided better visualization of lung parenchyma, mediastinal detail and position of endotracheal tubes than conventional radiography. Central venous catheters were generally seen better on conventional radiographs than on Insight. Insight system produces a significant improvement in plain chest radiography in the intensive care unit. In the absence of digital radiography it is a suitable technique for routine radiography in the intensive care unit.
- Published
- 1996
- Full Text
- View/download PDF
156. 1014 Functional outcomes of rendezvous procedure to treat complex ureteric discontinuities
- Author
-
M. Bolgeri, Clare Allen, R. Dale, S. Allen, T. Philp, P. Pallavi, S. Choong, Navin Ramachandran, Daron Smith, and G. Mazzon
- Subjects
business.industry ,Urology ,Rendezvous ,Calculus ,Medicine ,Classification of discontinuities ,business - Published
- 2016
- Full Text
- View/download PDF
157. 1444 WHAT BURDEN OF PROSTATE CANCER IS MISSED BY A NEGATIVE MULTI-PARAMETRIC MRI? AN ANALYSIS BASED ON TEMPLATE PROSTATE MAPPING AS THE REFERENCE STANDARD
- Author
-
Nimalan Arumainayagam, Alex Freeman, Alex Kirkham, S. A. Aslam Sohaib, Hashim U. Ahmed, Mark Emberton, and Clare Allen
- Subjects
Oncology ,medicine.medical_specialty ,Prostate cancer ,Multi parametric ,medicine.anatomical_structure ,business.industry ,Prostate ,Urology ,Internal medicine ,medicine ,business ,medicine.disease ,Reference standards - Published
- 2012
- Full Text
- View/download PDF
158. 2049 MAGNETIC RESONANCE IMAGE-GUIDED PROSTATE BIOPSY VERSUS TRANSPERINEAL TEMPLATE PROSTATE BIOPSY IN THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER
- Author
-
Clare Allen, Mark Emberton, Jan van der Meulen, Veeru Kasivisvanathan, Alex Freeman, Hashim U. Ahmed, Robert Dufour, Susan C. Charman, and Caroline M. Moore
- Subjects
medicine.medical_specialty ,Prostate cancer ,Prostate biopsy ,medicine.diagnostic_test ,business.industry ,Urology ,medicine ,Magnetic resonance imaging ,Radiology ,business ,medicine.disease - Published
- 2012
- Full Text
- View/download PDF
159. 1441 THE ROLE OF MULTIPARAMETRIC MRI IN MEN WITH NEGATIVE BIOPSY AND ELEVATED PSA - CAN IT RULE OUT CLINICALLY SIGNIFICANT DISEASE?
- Author
-
Alex Freeman, Hashim U. Ahmed, Mark Emberton, Clare Allen, Alex Kirkham, Mohamed Abd Alazeez, and Caroline M. Moore
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Urology ,Biopsy ,medicine ,Multiparametric MRI ,Disease ,Radiology ,business ,Elevated PSA - Published
- 2012
- Full Text
- View/download PDF
160. The natural history of untreated prostate MRI lesions in an active surveillance prostate cancer population – 260 patient-years
- Author
-
Hashim U. Ahmed, Clare Allen, Daniel Stevens, Mark Emberton, Alex Kirkham, Jan van der Meulen, and Caroline M. Moore
- Subjects
Parathyroidectomy ,Hyperparathyroidism ,education.field_of_study ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Urinary system ,Population ,Urology ,Retrospective cohort study ,General Medicine ,urologic and male genital diseases ,medicine.disease ,Medicine ,Blood test ,Surgery ,business ,Prospective cohort study ,education ,Primary hyperparathyroidism - Abstract
Background: Hyperparathyriodism is associated with an increase risk of developing renal calculi. The aim of this study was to quantify the incidence of renal calculi in patients undergoing parathyroidectomy. Method: A retrospective study of 38 patients that have undergone parathyroidectomy between 2002 and 2009 was performed. Patient age, mode of discovery, serum levels of biochemical markers and types of renal imaging were evaluated. Results: 38 patients (7 male), median age 59 (range 31-79) were reviewed. All patients were diagnosed with primary hyperparathyroidism incidentally. Histology of parathyroids showed 9 nodular hyperplasias and 29 parathyroid adenomas. Median adjusted calcium is 2.87 (range 2.62 5.3), median parathyroid hormone level is 15.2 (range 6.6 114.8). 6 (15%) had a 24 hour urine calcium level test and 4 (10%) had renal stone. 13 (31%) out of 18 patients (USS1⁄45, CT KUB1⁄43, IVU1⁄43, abdominal x-ray1⁄42) who have undergone renal imaging had renal calculi. 6 (16%) had renal calculi detected before confirmatory blood test for hyperparathyroidism. Conclusion: Ultrasound scan of the kidneys could be recommended for all parathyroidectomy patients. A prospective study with 24 hours urinary metabolic work upmight help to answer the relationship between primary hyperparthyroidism and urolithiasis.
- Published
- 2012
- Full Text
- View/download PDF
161. The Role of MRI in Active Surveillance
- Author
-
Caroline M. Moore, Clare Allen, and Mark Emberton
- Subjects
medicine.medical_specialty ,Diffusion weighting ,medicine.diagnostic_test ,business.industry ,Gadolinium ,chemistry.chemical_element ,Magnetic resonance imaging ,Newly diagnosed ,medicine.disease ,Prostate cancer ,medicine.anatomical_structure ,chemistry ,Prostate ,medicine ,Effective diffusion coefficient ,Radiology ,business ,Lymph node - Abstract
The first use of magnetic resonance imaging in the prostate was an anatomical assessment of newly diagnosed prostate cancer. T1- and T2-weighted sequences were performed to look for local invasion and lymph node involvement. Developments in functional MRI, including the use of gadolinium enhancement, diffusion weighting and spectroscopy, have led to the use of MRI to detect prostate cancer within the gland. MRI can be used to assess the whole gland and preferentially detects prostate cancer of greater Gleason score and volume.
- Published
- 2012
- Full Text
- View/download PDF
162. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study
- Author
-
Clare Allen, Alex Kirkham, Hashim U. Ahmed, Mark Emberton, Alex Freeman, Paul Cathcart, and Neil McCartan
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Salvage therapy ,Disease-Free Survival ,Prostate cancer ,Interquartile range ,Prostate ,medicine ,Humans ,External beam radiotherapy ,Survival rate ,Ultrasound, High-Intensity Focused, Transrectal ,Aged ,Aged, 80 and over ,Salvage Therapy ,business.industry ,Cancer ,Prostatic Neoplasms ,Middle Aged ,Prostate-Specific Antigen ,medicine.disease ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,Treatment Outcome ,Oncology ,Radiology ,Neoplasm Recurrence, Local ,business - Abstract
BACKGROUND: The objective of this study was to evaluate the safety, feasibility, side-effect profile, and proof of concept for focal salvage therapy using high-intensity focused ultrasound (HIFU). METHODS: A registry-based analysis was conducted between 2004 and 2009 of 430 patients who underwent HIFU. Thirty-nine patients received focal salvage therapy for localized recurrence after external beam radiotherapy. Multiparametric magnetic resonance imaging studies combined with transperineal template prostate mapping biopsies or transrectal biopsies were used to localize disease. Validated questionnaires were used to assess functional outcomes. Biochemical failure was defined by using both Phoenix criteria (prostate-specific antigen [PSA] nadir plus 2 ng/mL) and Stuttgart criteria (PSA nadir plus 1.2 ng/mL). RESULTS: The mean pre-HIFU PSA level was 4.6 ng/mL. The median follow-up was 17 months (interquartile range, 10-29 months). International Index of Erectile Function-5 scores decreased from a median ± standard deviation (SD) of 18 ± 16 to 13 ± 21 at 6 months, demonstrating worsening function. Scores on the University of California Los Angeles-Expanded Prostate Cancer Index Composite Urinary domain indicate that pad-free, leak-free continence status was 64%, and the pad-free rate was 87.2% at last follow-up. One rectourethral fistula occurred and spontaneously resolved with urinary and bowel diversion. The actuarial progression-free survival rate (including PSA nonresponders) was 69% at 1 year and 49% at 2 years according to Phoenix criteria. Excluding PSA nonresponders, these rates were 74% and 58%, respectively (Phoenix criteria). CONCLUSIONS: The results from this study indicated that focal salvage therapy is a potential strategy for localized recurrence after radiotherapy that may reduce the harms resulting from whole-gland salvage therapies. Cancer 2012. © 2011 American Cancer Society.
- Published
- 2011
163. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy
- Author
-
Hashim, Uddin Ahmed, Paul, Cathcart, Venu, Chalasani, Andrew, Williams, Neil, McCartan, Alex, Freeman, Alex, Kirkham, Clare, Allen, Joseph, Chin, and Mark, Emberton
- Subjects
Aged, 80 and over ,Male ,Salvage Therapy ,Treatment Outcome ,Retreatment ,Humans ,Prostatic Neoplasms ,Middle Aged ,Neoplasm Recurrence, Local ,Disease-Free Survival ,Ultrasound, High-Intensity Focused, Transrectal ,Aged - Abstract
Whole-gland high-intensity focused ultrasound (HIFU) has been used as salvage therapy for local recurrence following external beam radiation therapy for decades. This article describes the use of the Sonablate 500 HIFU system in the salvage setting.An evaluation was performed of a consecutive group of men with biochemical failure after external beam radiation therapy with histologically proven local recurrence and bone-scan and pelvic magnetic resonance imaging to exclude macroscopic metastases, and who chose to have whole-gland salvage HIFU (Sonablate 500) at 2 centers (3 expert HIFU surgeons at each center). The modified Clavien system was used to categorize adverse events and validated questionnaires for functional outcomes. Progression following HIFU treatment was defined as ASTRO-Phoenix criteria (prostate serum antigen [PSA]nadir+2 ng/mL) and/or a positive biopsy and/or start of hormone therapy.Eighty-four men underwent whole-gland salvage HIFU (2004-2009). Median age, pretreatment serum PSA, and biopsy Gleason score was 68 years (range, 64-72 years), 4.3 ng/mL (range, 1.9-7.9 ng/mL), and 7 (range, 6-7), respectively. Mean follow-up was 19.8 months (range, 3.0-35.1 months). After salvage HIFU, 62% of the men were pad-free and leak-free. Mean International Index of Erectile Function-5 point score fell from 8.8 to 4.7 (P.001). International Prostate Symptoms Score and RAND-SF36 scores were not affected. Two men developed rectourethral fistulae after 1 salvage procedure. A further 2 fistulae occurred in the 6 men undergoing a second salvage HIFU. Intervention for bladder outlet obstruction was needed in 20% (17 of 84 patients). If PSA nonresponders were included, 1- and 2-year progression-free survival rates were 59% (50 of 84 patients) and 43% (36 of 84 patients), respectively. If PSA nonresponders were excluded, 1- and 2-year progression-free survival rates were 62% (48 of 77 patients) and 48% (37 of 77 patients), respectively.Salvage whole-gland HIFU is a high-risk procedure. Although its use in early cancer control is promising, strategies to better identify metastatic disease prior to salvage therapy and reduce local toxicity are needed to improve on this.
- Published
- 2011
164. 11 THE USE OF MAGNETIC RESONANCE IMAGING IN URO-RECTAL FISTULA
- Author
-
Anthony R. Mundy, Evangelos Zacharakis, Clare Allen, Krishnan Venkatesan, and Daniela E. Andrich
- Subjects
Physics of magnetic resonance imaging ,Nuclear magnetic resonance ,medicine.diagnostic_test ,business.industry ,Interventional magnetic resonance imaging ,Magnetic resonance microscopy ,Urology ,Medicine ,Magnetic resonance imaging ,business ,Rectal fistula - Published
- 2011
- Full Text
- View/download PDF
165. 1806 CORRELATION OF PROXIMAL AND DISTAL CORPUS CAVERNOSUM BIOPSY WITH COLOUR DOPPLER ULTRASONOGRAPHY IN ISCHAEMIC PRIAPISM
- Author
-
Suks Minhas, Maj Shabbir, Alex Freeman, Clare Allen, Asif Muneer, Evangelos Zacharakis, David Ralph, and Alex Kirkham
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Urology ,Biopsy ,Medicine ,Colour doppler ultrasonography ,Radiology ,business ,Ischaemic priapism - Published
- 2011
- Full Text
- View/download PDF
166. 1788 RESULTS OF TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR LOW RISK LOCALIZED PROSTATE CANCER (PCM203)
- Author
-
Abdel-Rahmene Azzouzi, Eric Barret, Arnaud Villers, Gordon Muir, Caroline Moore, Clare Allen, and Mark Emberton
- Subjects
Urology - Published
- 2011
- Full Text
- View/download PDF
167. 2314 A NEGATIVE MULTI-PARAMETRIC MRI CAN RULE-OUT UP TO 97% OF CLINICALLY SIGNIFICANT PROSTATE CANCER
- Author
-
Nimalan Arumainayagam, Hashim Ahmed, Caroline Moore, Alex Freeman, Aslam Sohaib, Alex Kirkham, Clare Allen, and Mark Emberton
- Subjects
Urology - Published
- 2011
- Full Text
- View/download PDF
168. 1541 DISTAL CORPUS CAVERNOSUM SMOOTH MUSCLE FIBROSIS DUE TO NON-ISCHAEMIC PRIAPISM- SHOULD EMBOLISATION BE PERFORMED EARLIER?
- Author
-
Suks Minhas, Maj Shabbir, Clare Allen, Miles Walkden, Evangelos Zacharakis, David Ralph, Asif Muneer, and Alex Kirkham
- Subjects
Duplex ultrasonography ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Urology ,medicine.medical_treatment ,Priapism ,Penile implant ,Anatomy ,medicine.disease ,film.subject ,medicine.anatomical_structure ,Erectile dysfunction ,film ,Angiography ,Penile Tumescence ,Medicine ,Embolization ,business ,Penis - Abstract
INTRODUCTION AND OBJECTIVES: Non-ischaemic priapism is due to unregulated cavernous arterial inflow. Although rare, it is commonly associated with perineal or penile trauma. Since the venous outflow mechanism is unaffected the corpus cavernosum is perfused with oxygenated blood and therefore these patients can be managed conservatively. We report on our series of patients with non-ischaemic priapism who have developed fibrosis of the distal corpus cavernosum following a period of conservative treatment. METHODS: Over a 5 year period, 7 patients with non-ischaemic priapism presented to our unit. The mean age was 37.4 years (range 20 56). The etiology in 6 cases was secondary to a perineal injury and in 1 case conversion of an ischaemic priapism to a non ischaemic priapism following surgical intervention. The diagnosis of non-ischaemic priapism in all patients was based on the clinical history and examination, cavernosal blood gas analysis, colour duplex ultrasonography of the penis and pudendal angiography. 4 cases (57%) also underwent a penile MRI. RESULTS: Although the diagnostic tests confirmed non-ischaemic priapism, follow up Doppler studies and MRI penis showed the development of distal corpus cavernosum fibrosis. Pudendal artery super selective embolization was eventually performed in all of the patients, of which 2 (28.5%) patients underwent a second attempt at embolisation. On follow up these patients reported the development of erectile dysfunction due to poor distal penile tumescence in all cases and the penile MRI demonstrated distal corpus cavernosum fibrosis. Four patients (57%) eventually underwent insertion of a penile implant due to failed pharmacotherapies. A further 3 (43%) patients are using PDE-5 inhibitors. The conditions were reproduced in an in vitro model using precontracted strips of rabbit corpus cavernosum superfused at high pO2 levels. This showed that the smooth muscle tone reduced by 43% of the initial tone (n 4) after superfusion for 12 hours indicating irreversible smooth muscle dysfunction. CONCLUSIONS: The risk of ischaemic damage in non-ischaemic priapism is expected to be minimal due to the oxygenation of the corpus cavernosum being maintained. However, corpus cavernosum perfusion with higher than normal pO2 levels may result in oxidative stress due to the formation of reactive oxygen species (ROS). Irreversible damage to the smooth muscle is followed by the development of fibrosis, Based on these findings we suggest that superselective embolisation of these cases should be performed at the earliest opportunity.
- Published
- 2011
- Full Text
- View/download PDF
169. Light penetration in the human prostate: a whole prostate clinical study at 763 nm
- Author
-
Clare Allen, C. Alexander Mosse, Heather Payne, Mark Emberton, Stephen G. Bown, and Caroline M. Moore
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Materials science ,Light ,medicine.medical_treatment ,Brachytherapy ,Biomedical Engineering ,Photodynamic therapy ,Sensitivity and Specificity ,Biomaterials ,Prostate cancer ,Prostate ,Nephelometry and Turbidimetry ,medicine ,Humans ,Scattering, Radiation ,Photosensitizer ,Penetration depth ,Prostatic Neoplasms ,Reproducibility of Results ,Penetration (firestop) ,medicine.disease ,Atomic and Molecular Physics, and Optics ,High-Dose Rate Brachytherapy ,Electronic, Optical and Magnetic Materials ,medicine.anatomical_structure ,Biomedical engineering - Abstract
Photodynamic therapy (PDT) is being investigated as a treatment for localized prostate cancer. Photodynamic therapy uses a photosensitizing drug which is activated by a specific wavelength of light, in the presence of oxygen. The activated drug reacts with tissue oxygen to produce reactive oxygen species which are responsible for localized tissue necrosis. One of the determinants of the PDT effect is the penetration of light in the prostate. This study assesses the penetration depth of 763 nm light throughout the prostate. Eight men undergoing multiple hollow needle insertion for high dose rate brachytherapy were recruited. 763 nm light, produced by a diode laser, was delivered to the prostate using cylindrically diffusing optical fibers within the plastic needles. Light was detected at different distances from the source, using an isotropic detector within nearby needles. Penetration depth was calculated using the Boltzmann approximation to the diffusion equation. Delivery detector fiber separation was measured on computed tomography. The mean penetration depth was 0.57 cm, but there was within patient variation of a mean factor of 4.3. Further work is ongoing to assess the effect of such variability in light penetration, on the PDT effect.
- Published
- 2011
170. Multiple virus infections occur in individual polygyne and monogyne Solenopsis invicta ants
- Author
-
Charles A. Strong, Clare Allen, and Steven M. Valles
- Subjects
Male ,Insecticides ,Fire ant ,Picornaviridae Infections ,biology ,Ants ,Reverse Transcriptase Polymerase Chain Reaction ,Insect Viruses ,Picornaviridae ,biology.organism_classification ,Viral infection ,Virology ,Virus ,Multiple infections ,Sexual Behavior, Animal ,Host-Pathogen Interactions ,Viral Interference ,Animals ,RNA, Viral ,Female ,Pest Control, Biological ,Social Behavior ,Ecology, Evolution, Behavior and Systematics - Abstract
Concurrent infections of Solenopsis invicta colonies with S. invicta virus 1 (SINV-1), SINV-2, and SINV-3 has been reported. However, whether individual ants were capable of supporting multiple virus infections simultaneously was not known, nor whether the social form of the colony (polygyne or monogyne) had an influence on the occurrence of multiple infection rates in individual ants. S. invicta field populations were sampled sequentially to establish whether multiple virus infections co-occurred in individual worker ants. In addition, the intra-colony virus infection rates were compared in monogyne and polygyne field colonies to determine whether social form played a role in the viral infection prevalence. All combinations of virus infection (SINV-1, SINV-2, or SINV-3 alone, SINV-1 & SINV-2, SINV-1 & SINV-3, SINV-2 & SINV-3, and SINV-1, SINV-2 & SINV-3) were detected in individual worker ants as well as queens in the field. Thus, individual S. invicta ants can be infected simultaneously with all combinations of the S. invicta viruses. Colony social form did have an influence on the intra-colony prevalence of multiple S. invicta virus infections. Polygyne colonies exhibited significantly greater intra- and inter-colony single and multiple virus infections compared with monogyne colonies.
- Published
- 2011
171. Reliability of a Rating Scale for Measuring Speech Intelligibility After Pediatric Cochlear Implantation
- Author
-
Dee Dyar, Clare Allen, Thomas P. Nikolopoulos, and Gerard M. O'Donoghue
- Subjects
medicine.medical_specialty ,Validation study ,Hearing loss ,Deafness ,Audiology ,Intelligibility (communication) ,Rating scale ,otorhinolaryngologic diseases ,medicine ,Humans ,Statistical analysis ,Prospective Studies ,Child ,Cochlear implantation ,Verbal Behavior ,business.industry ,Speech Intelligibility ,Follow up studies ,Infant ,Reproducibility of Results ,Cochlear Implantation ,Sensory Systems ,Otorhinolaryngology ,Child, Preschool ,sense organs ,Neurology (clinical) ,medicine.symptom ,business ,Follow-Up Studies - Abstract
To evaluate the reliability of the Speech Intelligibility Rating scale to monitor the speech intelligibility of deaf children who have received cochlear implants.A prospective study assessing the speech intelligibility of deaf children with cochlear implants by local and cochlear implant program speech and language therapists.Pediatric tertiary referral center for cochlear implantation.Fifty-four children were each rated by two speech and language therapists, one working with the child locally and the other working with the child at the cochlear implant program. All children were between 1.2 and 10.9 years of age at the time of implantation (median, 4.0 years). The follow-up intervals ranged from before implantation to 9 years after implantation.Correlation coefficient, intraclass correlation coefficient, and kappa statistics were used to assess the interobserver reliability of the Speech Intelligibility Rating scale.Spearman rank correlation coefficient and intraclass correlation coefficient were 0.82 with high statistical significance (p0.00001). Kappa statistical analysis revealed a moderate to substantial agreement between the ratings. This agreement also reached a high statistical significance (overall kappa = 0.53, p0.000001). The Speech Intelligibility Rating scale was found to be able to discriminate speech intelligibility among subjects, and the ratings covaried with high consistency.The study found a high rate of agreement between observers when they used the Speech Intelligibility Rating scale to assess the speech intelligibility of deaf children after cochlear implantation. Because the scale presents information in a format that is understood by parents, local professionals, and health care purchasers, it will be useful to provide them with accessible information on speech intelligibility outcomes of deaf children who have received cochlear implants.
- Published
- 2001
- Full Text
- View/download PDF
172. The effects of the time period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer
- Author
-
Louise Dickinson, Hashim Uddin Ahmed, Caroline Moore, Alex Freeman, Alex Kirkham, Clare Allen, and Mark Emberton
- Subjects
Male ,Time Factors ,Urology ,Biopsy ,Prostate ,Humans ,Prostatic Neoplasms ,Magnetic Resonance Imaging ,Neoplasm Staging - Published
- 2010
173. MR to ultrasound image registration for guiding prostate biopsy and interventions
- Author
-
Yipeng, Hu, Hashim Uddin, Ahmed, Clare, Allen, Doug, Pendsé, Mahua, Sahu, Mark, Emberton, David, Hawkes, and Dean, Barratt
- Subjects
Male ,Biopsy ,Prostatic Neoplasms ,Reproducibility of Results ,Image Enhancement ,Radiography, Interventional ,Sensitivity and Specificity ,Pattern Recognition, Automated ,Imaging, Three-Dimensional ,Surgery, Computer-Assisted ,Artificial Intelligence ,Subtraction Technique ,Image Interpretation, Computer-Assisted ,Humans ,Algorithms - Abstract
A method is described for registering preoperative magnetic resonance (MR) to intraoperative transrectal ultrasound (TRUS) images of the prostate gland. A statistical motion model (SMM) of the prostate is first built using training data provided by biomechanical simulations of the motion of a patient-specific finite element model, derived from a preoperative MR image. The SMM is then registered to a 3D TRUS image by maximising the likelihood of the shape of an SMM instance given a voxel-intensity-based feature, which represents an estimate of normal vector at the surface of the prostate gland. Using data acquired from 7 patients, the accuracy of registering T2 MR to 3D TRUS images was evaluated using anatomical landmarks inside the gland. The results show that the proposed registration method has a root-mean-square target registration error of 2.66 mm.
- Published
- 2010
174. Exploitation of a high genomic mutation rate in Solenopsis invicta virus 1 to infer demographic information about its host, Solenopsis invicta
- Author
-
David H. Oi, Clare Allen, Steven M. Valles, Juan A. Briano, and Laura Varone
- Subjects
Molecular Sequence Data ,Argentina ,Taiwan ,Genome, Viral ,Biology ,DNA sequencing ,Serine ,Phylogenetics ,Valine ,Animals ,Amino Acid Sequence ,Threonine ,Ecology, Evolution, Behavior and Systematics ,Phylogeny ,Demography ,Polyproteins ,Genetics ,chemistry.chemical_classification ,Phylogenetic tree ,Ants ,United States ,Amino acid ,chemistry ,Mutation ,Dicistroviridae ,Isoleucine - Abstract
The RNA-dependent RNA polymerase (RdRp) region of Solenopsis invicta virus 1 (SINV-1) was sequenced from 47 infected colonies of S. invicta , S. richteri , S. geminata , and S. invicta / richteri hybrids collected from across the USA, northern Argentina, and northern Taiwan in an attempt to infer demographic information about the recent S. invicta introduction into Taiwan by phylogenetic analysis. Nucleotide sequences were calculated to exhibit an overall identity of >90% between geographically-separated samples. A total of 171 nucleotide variable sites (representing 22.4% of the region amplified) were mapped across the SINV-1 RdRp alignment and no insertions or deletions were detected. Phylogenetic analysis at the nucleotide level revealed clustering of Argentinean sequences, distinct from the USA sequences. Moreover, the SINV-1 RdRp sequences derived from recently introduced populations of S. invicta from northern Taiwan resided within the multiple USA groupings implicating the USA as the source for the recent introduction of S. invicta into Taiwan. Examination of the amino acid alignment for the RdRp revealed sequence identity >98% with only nine amino acid changes observed. Seven of these changes occurred in less than 4.3% of samples, while 2 (at positions 1266 and 1285) were featured prominently. Changes at positions 1266 and 1285 accounted for 36.2% and 34.0% of the samples, respectively. Two distinct groups were observed based on the amino acid residue at position 1266, Threonine or Serine. In cases where this amino acid was a Threonine, 90% of these sequences possessed a corresponding Valine at position 1285; only 10% of the Threonine 1266 -containing sequences possessed an Isoleucine at the 1285 position. Among the Serine 1266 group, 76% possessed an Isoleucine at position 1285, while only 24% possessed a Valine. Thus, it appears that the Threonine 1266 /Valine 1285 and Serine 1266 /Isoleucine 1285 combinations are predominant phenotypes.
- Published
- 2010
175. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy
- Author
-
Nimalan, Arumainayagam, Senthil, Kumaar, Hashim U, Ahmed, Caroline M, Moore, Heather, Payne, Alex, Freeman, Clare, Allen, Alex, Kirkham, and Mark, Emberton
- Subjects
Male ,Prostate ,Humans ,Prostatic Neoplasms ,Middle Aged ,Neoplasm Recurrence, Local ,Reference Standards ,Magnetic Resonance Imaging ,Aged ,Retrospective Studies - Abstract
To assess the role of multiparametric magnetic resonance imaging (mp-MRI) of the prostate in evaluating local recurrence of prostate cancer, using transperineal template-guided 5 mm-spaced biopsies as a reference standard, in men treated with external beam radiotherapy (EBRT) for prostate cancer.The study included 13 patients with evidence of biochemical recurrence after EBRT who had undergone mp-MRI and prostate mapping. Each MRI scan (consisting of T1/T2 weighting, dynamic contrast enhancement and diffusion weighting) was reported by two expert uro-radiologists. Each prostate was divided into four regions of interest (ROI), generating 52 paired datasets for analysis.The mean (range) age of the men was 65.5 (55-70) years, the mean prostate-specific antigen (PSA) level before EBRT was 36.6 (4.5-150) ng/mL, the mean time from EBRT to biochemical recurrence was 5.7 (3-10) years and the mean PSA level at the time of recurrence was 7.1 (0.83-27.9) ng/mL. Eleven men had histological evidence of recurrence, with 23 of 52 ROIs involved with cancer. Overall accuracy, as expressed by the area under a receiver-operator curve, was 0.77 and 0.89 for all cancer, with accuracies of 0.86 and 0.93 for those cancers with ≥3 mm biopsy core length. Inter-observer variability was measured by calculating κ coefficients, which showed fair and moderate agreement between radiologists.Interpretation of mpMRI of the prostate after previous EBRT is challenging. Our results show that the accuracy is good using an accurate reference standard. These results need verification in more patients, but have implications for determining presence or absence of local recurrence and subsequent local salvage therapy.
- Published
- 2010
176. Complete genome sequence of an Argentinean isolate of Solenopsis invicta virus 3
- Author
-
Juan A. Briano, Clare Allen, Laura Varone, and Steven M. Valles
- Subjects
Sequence analysis ,Molecular Sequence Data ,Argentina ,Genome, Viral ,Biology ,Genome ,Open Reading Frames ,Viral Proteins ,Start codon ,Virology ,Sequence Homology, Nucleic Acid ,Genetics ,Animals ,Point Mutation ,RNA Viruses ,Molecular Biology ,Gene ,Sequence Homology, Amino Acid ,Ants ,Nucleic acid sequence ,General Medicine ,Sequence Analysis, DNA ,Stop codon ,Open reading frame ,GenBank ,RNA, Viral - Abstract
Solenopsis invicta virus 3 (SINV-3) is a recently described positive-strand RNA virus that infects the red imported fire ant, S. invicta. The genome of an Argentinean isolate of Solenopsis invicta virus 3 (SINV-3(ArgSF )) obtained from the Santa Fe region of Argentina was sequenced in entirety. Assembly of nine overlapping fragments yielded a consensus genome sequence 10,386 nucleotides long, excluding the poly(A) tail present on the 3' end (Genbank accession number GU017972). With the exception of the poly(A) tail, the genome length of SINV-3(ArgSF ) was identical to the North American isolate (SINV-3(USDM )). The SINV-3(ArgSF ) genome possessed three major open reading frames (ORFs) (comprised ofor=100 codons) in the sense orientation; SINV-3(USDM ) possessed only two. ORFs 1 and 2 had identical start and stop genome positions for both isolates. Blastp analysis of the translated ORF 1 of SINV-3(ArgSF ) recognized conserved domains for helicase, protease, and RNA-dependent RNA polymerase. These domains and their corresponding positions were identical to those reported for SINV-3(USDM ). ORF 2a, unique to the SINV-3(ArgSF ) genome, was also found in frame 2 and had a canonical start codon located at nucleotide position 8,351 and a stop codon ending at position 8,827. Blastp analysis of the translated amino acid sequence of ORF 2a revealed no significant similarity in the Genbank database. The two SINV-3 isolates exhibited 96.2% nucleotide sequence identity across the entire genome. The amino acid sequences of ORFs 1 and 2 exhibited higher identities (99.0 and 98.2%, respectively) than the corresponding nucleotide regions within the genome. These data indicated that the nucleotide differences between the SINV-3 isolates were largely synonymous. This observation was corroborated by codon substitution rate analysis. Thus, the majority of the SINV-3 codon changes were silent in the two polyproteins, indicating purifying selection pressure on the viral genome.
- Published
- 2009
177. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series
- Author
-
Tim Dudderidge, Hashim U. Ahmed, R. Scott, Rowland Illing, Alex Kirkham, James N. Armitage, Mark Emberton, Evangelos Zacharakis, Chris Ogden, A. Freeman, J. Calleary, and Clare Allen
- Subjects
Male ,Cancer Research ,Urethral stricture ,medicine.medical_treatment ,high-intensity-focused ultrasound ,Biopsy ,Urinary incontinence ,GUIDELINES ,RECOMMENDATIONS ,Prostate cancer ,STANDARD ,Clinical Studies ,FAILURE ,Sonablate500 ,Ultrasound, High-Intensity Focused, Transrectal ,transrectal ,Aged, 80 and over ,RADICAL PROSTATECTOMY ,MEN ,Middle Aged ,prostate cancer ,Prostate-specific antigen ,Treatment Outcome ,medicine.symptom ,Epididymitis ,Urinary Catheterization ,Life Sciences & Biomedicine ,medicine.medical_specialty ,Adenocarcinoma ,Urinary catheterization ,Disease-Free Survival ,RADIATION-THERAPY ,medicine ,Humans ,External beam radiotherapy ,Oncology & Carcinogenesis ,Letters to the Editor ,Aged ,Neoplasm Staging ,Science & Technology ,business.industry ,Prostatic Neoplasms ,HIFU ,Prostate-Specific Antigen ,medicine.disease ,ONCOLOGY ,United Kingdom ,Surgery ,Radiation therapy ,TRANSRECTAL HIFU ,EXPERIENCE ,business ,1112 Oncology And Carcinogenesis - Abstract
Background: The use of minimally invasive ablative therapies in localised prostate cancer offer potential for a middle ground between active surveillance and radical therapy. Methods: An analysis of men with organ-confined prostate cancer treated with transrectal whole-gland HIFU (Sonablate 500) between 1 February 2005 and 15 May 2007 was carried out in two centres. Outcome data (side-effects using validated patient questionnaires, biochemical, histology) were evaluated. Results: A total of 172 men were treated under general anaesthetic as day-case procedures with 78% discharged a mean 5 h after treatment. Mean follow-up was 346 days (range 135–759 days). Urethral stricture was significantly lower in those with suprapubic catheter compared with urethral catheters (19.4 vs 40.4%, P=0.005). Antibiotics were given to 23.8% of patients for presumed urinary tract infection and the rate of epididymitis was 7.6%. Potency was maintained in 70% by 12 months, whereas mild stress urinary incontinence (no pads) was reported in 7.0% (12 out of 172) with a further 0.6% (1 out of 172) requiring pads. There was no rectal toxicity and no recto-urethral fistulae. In all, 78.3% achieved a PSA nadir ⩽0.5 μg ml−1 at 12 months, with 57.8% achieving ⩽0.2 μg ml−1. Then, 8 out of 13 were retreated with HIFU, one had salvage external beam radiotherapy and four chose active surveillance for small-volume low-risk disease. Overall, there was no evidence of disease (PSA
- Published
- 2009
178. Is it time to consider a role for MRI before prostate biopsy?
- Author
-
Alex Freeman, Hashim U. Ahmed, Alex Kirkham, Mark Emberton, Clare Allen, Rowland Illing, and Manit Arya
- Subjects
Male ,medicine.medical_specialty ,Prostate biopsy ,medicine.medical_treatment ,Risk Assessment ,Sensitivity and Specificity ,Endosonography ,Management of prostate cancer ,Prostate cancer ,Biopsy ,medicine ,Humans ,Mass Screening ,Early Detection of Cancer ,Neoplasm Staging ,medicine.diagnostic_test ,business.industry ,Biopsy, Needle ,Prostate ,Prostatic Neoplasms ,Prostate-Specific Antigen ,medicine.disease ,Prognosis ,Magnetic Resonance Imaging ,Surgery ,Radiation therapy ,Oncology ,Risk stratification ,Radiology ,business ,Radical retropubic prostatectomy ,Antigen levels - Abstract
The use of MRI in prostate cancer management is controversial and current guidelines underplay its role. Technological advances over the past 5 years, however, demand a re-evaluation of this position. In this article, we propose an increased use of MRI, not only in those with a diagnosis of prostate cancer but also for men before a prostate biopsy. The use of MRI before a biopsy can serve as a triage test in men with raised serum prostate-specific antigen levels, in order to select those for biopsy with significant cancer that requires treatment. This strategy could avoid biopsy, and hence unnecessary treatment, in those with no disease or insignificant cancer. In addition, avoidance of postbiopsy artifact caused by hemorrhage will lead to better local staging accuracy, while determining more accurately the disease burden. This approach could improve risk stratification by selecting those who require adjuvant therapy or dose escalation. Furthermore, MRI evaluation of cancer burden could be important in active surveillance regimens to select those needing intervention.
- Published
- 2009
179. Targeted testicular excision biopsy: when and how should we try to avoid radical orchidectomy?
- Author
-
Alex Freeman, Clare Allen, Suks Minhas, Alex Kirkham, David Ralph, Pardeep Kumar, and Asif Muneer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Biopsy ,Testis sparing surgery ,Unnecessary Procedures ,Excision biopsy ,Testicular Diseases ,Lesion ,Diagnosis, Differential ,Young Adult ,Testicular Neoplasms ,Testis ,medicine ,Frozen Sections ,Humans ,Radiology, Nuclear Medicine and imaging ,Ultrasonography, Interventional ,Frozen section procedure ,Incidental Findings ,medicine.diagnostic_test ,business.industry ,General Medicine ,Epidermoid cyst ,medicine.disease ,Magnetic Resonance Imaging ,Surgery ,Testicular function ,medicine.symptom ,business ,Orchiectomy - Abstract
Small, incidental testicular lesions are often benign, but in the past have usually been treated by orchidectomy. An alternative is an operative excision biopsy, with localization by ultrasound if necessary, and characterization of the lesion by frozen section analysis. The present review summarizes the indications for the procedure, lists the likely diagnoses, and describes the technique. Frozen section is accurate for distinguishing benign from malignant lesions, testicular function is usually preserved, and there is no evidence that oncological safety is impaired. Such testis-preserving surgery is a rewarding ground for collaboration between urologists, radiologists, and pathologists.
- Published
- 2009
180. MR to Ultrasound Image Registration for Guiding Prostate Biopsy and Interventions
- Author
-
Hashim U. Ahmed, David J. Hawkes, Yipeng Hu, M. Sahu, Clare Allen, Doug Pendse, Mark Emberton, and Dean C. Barratt
- Subjects
medicine.medical_specialty ,Prostate biopsy ,medicine.diagnostic_test ,business.industry ,Trus image ,Ultrasound ,Magnetic resonance imaging ,medicine.anatomical_structure ,Prostate ,Feature (computer vision) ,medicine ,Radiology ,Prostate gland ,business ,Ultrasound image - Abstract
A method is described for registering preoperative magnetic resonance (MR) to intraoperative transrectal ultrasound (TRUS) images of the prostate gland. A statistical motion model (SMM) of the prostate is first built using training data provided by biomechanical simulations of the motion of a patient-specific finite element model, derived from a preoperative MR image. The SMM is then registered to a 3D TRUS image by maximising the likelihood of the shape of an SMM instance given a voxel-intensity-based feature, which represents an estimate of normal vector at the surface of the prostate gland. Using data acquired from 7 patients, the accuracy of registering T2 MR to 3D TRUS images was evaluated using anatomical landmarks inside the gland. The results show that the proposed registration method has a root-mean-square target registration error of 2.66 mm.
- Published
- 2009
- Full Text
- View/download PDF
181. A statistical motion model based on biomechanical simulations for data fusion during image-guided prostate interventions
- Author
-
Yipeng, Hu, Dominic, Morgan, Hashim Uddin, Ahmed, Doug, Pendsé, Mahua, Sahu, Clare, Allen, Mark, Emberton, David, Hawkes, and Dean, Barratt
- Subjects
Male ,Prostatectomy ,Motion ,Models, Statistical ,Surgery, Computer-Assisted ,Humans ,Prostatic Neoplasms ,Computer Simulation ,Artifacts ,Image Enhancement ,Models, Biological ,Biophysical Phenomena ,Ultrasonography, Interventional - Abstract
A method is described for generating a patient-specific, statistical motion model (SMM) of the prostate gland. Finite element analysis (FEA) is used to simulate the motion of the gland using an ultrasound-based 3D FE model over a range of plausible boundary conditions and soft-tissue properties. By applying principal component analysis to the displacements of the FE mesh node points inside the gland, the simulated deformations are then used as training data to construct the SMM. The SMM is used to both predict the displacement field over the whole gland and constrain a deformable surface registration algorithm, given only a small number of target points on the surface of the deformed gland. Using 3D transrectal ultrasound images of the prostates of five patients, acquired before and after imposing a physical deformation, to evaluate the accuracy of predicted landmark displacements, the mean target registration error was found to be less than 1.9 mm.
- Published
- 2008
182. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy
- Author
-
Clare Allen, A. Ishaq, Rowland Illing, Mark Emberton, R. Scott, Hashim U. Ahmed, Evangelos Zacharakis, and Alex Freeman
- Subjects
Male ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Salvage therapy ,Cryotherapy ,Urinary incontinence ,Adenocarcinoma ,Prostate cancer ,medicine ,Dysuria ,Humans ,External beam radiotherapy ,Ultrasound, High-Intensity Focused, Transrectal ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Prostatectomy ,Salvage Therapy ,business.industry ,Prostatic Neoplasms ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,High-intensity focused ultrasound ,Surgery ,Radiation therapy ,Treatment Outcome ,Feasibility Studies ,medicine.symptom ,Neoplasm Recurrence, Local ,business - Abstract
OBJECTIVES To investigate the use of minimally invasive high-intensity focused ultrasound (HIFU) as a salvage therapy in men with localized prostate cancer recurrence following external beam radiotherapy (EBRT). PATIENTS AND METHODS A review of 31 cases treated using the Sonablate® 500 HIFU device, between 1 February 2005 and 15 May 2007, was carried out. All men had presumed organ-confined, histologically confirmed recurrent prostate adenocarcinoma following EBRT. RESULTS The mean (range) age was 65 (57–80) years with a mean preoperative PSA level of 7.73 (0.20–20) ng/mL. The patients were followed for a mean (range) of 7.4 (3–24) months. Side-effects included stricture or intervention for necrotic tissue in 11 of the 31 patients (36%), urinary tract infection or dysuria syndrome in eight (26%), and urinary incontinence in two (7%). Recto-urethral fistula occurred in two men, although one was due to patient movement due to inadequate anaesthesia, so the ‘true’ rate is 3%. Half of the patients had PSA levels of
- Published
- 2008
183. MR imaging of nonmalignant penile lesions
- Author
-
Alexander P. S. Kirkham, Rowland O. Illing, Suks Minhas, and Clare Allen
- Subjects
Adult ,Male ,medicine.medical_specialty ,Penile Diseases ,Adolescent ,Urethral stricture ,medicine.medical_treatment ,Priapism ,Tunica albuginea (ovaries) ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,medicine.diagnostic_test ,business.industry ,Penile fracture ,Magnetic resonance imaging ,Penile prosthesis ,Middle Aged ,medicine.disease ,Image Enhancement ,Mr imaging ,Magnetic Resonance Imaging ,Erectile dysfunction ,Radiology ,business ,Penis - Abstract
Magnetic resonance (MR) imaging is potentially useful in the assessment of many benign penile diseases. When T1- and T2-weighted sequences are used, MR imaging can clearly delineate the tunica albuginea and can be used to diagnose penile fracture and Peyronie disease; in both conditions, MR imaging may help refine the surgical approach. It is also useful in cases of priapism; in these cases, intravenously administered contrast material can help assess the viability of the corpora cavernosa and the presence of penile fibrosis. In the assessment of a penile prosthesis, MR imaging provides excellent anatomic information and is the investigation of choice. In the evaluation of erectile dysfunction, MR imaging has limited value, and for urethral stricture, it has not yet proved adequately superior to other modalities to justify its routine use.
- Published
- 2008
184. A Statistical Motion Model Based on Biomechanical Simulations for Data Fusion during Image-Guided Prostate Interventions
- Author
-
Dominic Morgan, M. Sahu, Mark Emberton, Hashim U. Ahmed, Yipeng Hu, David J. Hawkes, Clare Allen, Doug Pendse, and Dean C. Barratt
- Subjects
Deformation (mechanics) ,business.industry ,Computer science ,Sensor fusion ,Finite element method ,medicine.anatomical_structure ,stomatognathic system ,Prostate ,Principal component analysis ,Displacement field ,medicine ,Range (statistics) ,Computer vision ,Boundary value problem ,Artificial intelligence ,business - Abstract
A method is described for generating a patient-specific, statistical motion model (SMM) of the prostate gland. Finite element analysis (FEA) is used to simulate the motion of the gland using an ultrasound-based 3D FE model over a range of plausible boundary conditions and soft-tissue properties. By applying principal component analysis to the displacements of the FE mesh node points inside the gland, the simulated deformations are then used as training data to construct the SMM. The SMM is used to both predict the displacement field over the whole gland and constrain a deformable surface registration algorithm, given only a small number of target points on the surface of the deformed gland. Using 3D transrectal ultrasound images of the prostates of five patients, acquired before and after imposing a physical deformation, to evaluate the accuracy of predicted landmark displacements, the mean target registration error was found to be less than 1.9mm.
- Published
- 2008
- Full Text
- View/download PDF
185. Extended budded virus formation and induction of apoptosis by an AcMNPV FP-25/p35 double mutant in Trichoplusia ni cells
- Author
-
Linda A. King, Susan D. J. Chapple, Robert D. Possee, Barbara J. Kelly, Clare Allen, and Carolyn Pritchard
- Subjects
Cancer Research ,viruses ,fungi ,Mutant ,Apoptosis ,Biology ,Spodoptera ,Moths ,Nucleocapsid Proteins ,biology.organism_classification ,Molecular biology ,Virus ,Nucleopolyhedroviruses ,Autographa californica ,Viral Proteins ,Infectious Diseases ,Capsid ,Virology ,Mutation ,Polyhedrin ,Trichoplusia ,Animals ,Cells, Cultured - Abstract
An Autographa californica nucleopolyhedrovirus (AcMNPV) mutant (AcdefrT) isolated from virus-infected Trichoplusia ni (TN-368) cells produced plasma membrane blebbing and caspase-3-like activity late in infection. It also synthesized less polyhedra, but displayed enhanced budded virus formation in TN-368 cells. This phenotype resulted from dual mutations in p35 and FP-25. In this study we showed that enhanced budded virus production occurs because the hourly rate of release of virus from AcdefrT-infected cells is higher than that for AcMNPV and it continues for longer. This may be the trigger for the induction of apoptosis late in AcdefrT-infected TN-368 cells. However, laddering of host DNA was absent in TN-368 cells infected with AcdefrT, but was observed in Spodoptera frugiperda cells. Very late polyhedrin protein production and occlusion body formation was reduced in AcdefrT-infected TN-368 cells, but chitinase and capsid late gene expression remained unchanged. The AcdefrT was rescued with a copy of a baculovirus iap3, to replace the absent p35. This modification abolished most plasma membrane blebbing in AcdefrT-infected TN-368 cells, but did not affect enhanced budded virus production. These data suggest that inhibitors of apoptosis are required in T. ni cells, particularly when the production of budded virus is enhanced.
- Published
- 2007
186. An Evaluation of Hemi-Ablation Therapy Using High-Intensity Focused Ultrasound in the Treatment of Localized Adenocarcinoma of the Prostate
- Author
-
Alex Kirkham, Rowland Illing, Clare Allen, Mark Emberton, Alex Freeman, and Hashim U. Ahmed
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Cancer ,medicine.disease ,Lower risk ,High-intensity focused ultrasound ,Surgery ,Prostate cancer ,medicine.anatomical_structure ,Prostate ,medicine ,Adenocarcinoma ,Radiology ,Radical surgery ,Stage (cooking) ,business - Abstract
The current choice for men with localised prostate cancer lies between active surveillance and radical therapy. The best evidence for the difference between these two extremes of care is 5% in terms of cancer‐related absolute mortality at 8 years. It is generally accepted that this small difference will decrease for men diagnosed in the PSA‐era.Therein lays a dilemma for men. If they choose active surveillance they accept anxiety of living with a cancer diagnosis and risk of under‐treatment in the long term. On the other hand, radical therapy carries significant toxicity (incontinence, impotence, rectal problems) because it treats the whole gland and damages surrounding structures in up to half of men. With increasing PSA screening practices men are diagnosed younger with lower risk disease — early stage, lower Gleason grade and lower volume of cancer. Many have unifocal or unilateral disease.We propose a new concept whereby only the tumour focus and a margin of normal tissue is treated. With emerging tec...
- Published
- 2007
- Full Text
- View/download PDF
187. 820 The importance of a visible lesion in imaging based active surveillance for prostate cancer
- Author
-
Clare Allen, Victor Abu, N. Petrides, Shonit Punwani, Caroline M. Moore, J. Coe, and M. Emberton
- Subjects
medicine.medical_specialty ,Pathology ,Prostate cancer ,business.industry ,Urology ,medicine ,Radiology ,Visible Lesion ,business ,medicine.disease - Published
- 2015
- Full Text
- View/download PDF
188. 324 Is PSA density a useful biomarker in the age of frequent imaging for prostate cancer?
- Author
-
Clare Allen, M. Emberton, Caroline M. Moore, Alex Kirkham, Victor Abu, Y. Philippou, Francesco Giganti, J. Coe, N. Petrides, and Shonit Punwani
- Subjects
Oncology ,PCA3 ,medicine.medical_specialty ,Prostate cancer ,business.industry ,Urology ,Internal medicine ,Psa density ,medicine ,Biomarker (medicine) ,business ,medicine.disease - Published
- 2015
- Full Text
- View/download PDF
189. How good is MRI at detecting and characterising cancer within the prostate?
- Author
-
Clare Allen, Mark Emberton, and Alexander Kirkham
- Subjects
Male ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Urology ,Cancer ,Prostatic Neoplasms ,Magnetic resonance imaging ,Method of analysis ,medicine.disease ,Magnetic Resonance Imaging ,Sensitivity and Specificity ,Focal therapy ,Diagnosis, Differential ,Prostate cancer ,medicine.anatomical_structure ,Transrectal biopsy ,Prostate ,medicine ,Transrectal ultrasonography ,Humans ,Radiology ,business - Abstract
Objectives: As well as detecting prostate cancer, it is becoming increasingly important to estimate its location, size and grade. We aim to summarise current data on the efficacy of magnetic resonance imaging (MRI) in this setting. Methods: Literature review of original research correlating MRI and histologic appearances. Results: Estimates of the sensitivity of MRI for the detection of cancer vary widely depending on method of analysis used and the definition of significant disease. Recent estimates using T2-weighted sequences and endorectal coils vary from 60% to 96%. Several groups have convincingly shown that dynamic contrast enhancement and spectroscopy each improve detection and that the sensitivity of MRI is comparable to and may exceed that of transrectal biopsy. Specificity is not yet good enough to consider the use of MRI in screening. High-grade and large tumours are detected significantly more often with both T2 sequences and spectroscopy. Estimation of size is improved by dynamic contrast and spectroscopy, but errors of >25% are common. Conclusions: The sensitivity of MRI has improved to the point that it has potential in several new areas: targeting of biopsies, monitoring of disease burden both during active surveillance and after focal therapy, and exclusion of cancer in patients with a raised prostate-specific antigen level.
- Published
- 2006
190. 218 Association of level of suspicion of prostate cancer on multi-parametric MRI with detection rate of prostate cancer
- Author
-
Clare Allen, Hashim U. Ahmed, Veeru Kasivisvanathan, Mohamed Abd-Alazeez, M. Emberton, A. Freeman, Susan A. Charman, Robert Dufour, Alex Kirkham, J van der Meulen, and Caroline M. Moore
- Subjects
PCA3 ,Oncology ,medicine.medical_specialty ,Prostate cancer ,Multi parametric ,business.industry ,Urology ,Internal medicine ,Medicine ,Detection rate ,business ,medicine.disease - Published
- 2013
- Full Text
- View/download PDF
191. 717 Transperineal MRI-targeted biopsy versus transperineal template prostate mapping biopsy in the detection of localised radio-recurrent prostate cancer
- Author
-
Manit Arya, Hashim U. Ahmed, Abi Kanthabalan, Shonit Punwani, Alex Freeman, Mohammed Abl-Azzeez, Mark Emberton, Clare Allen, and Alex Kirkham
- Subjects
medicine.medical_specialty ,medicine.anatomical_structure ,medicine.diagnostic_test ,business.industry ,Prostate ,Urology ,Biopsy ,Medicine ,Recurrent prostate cancer ,business ,Targeted biopsy - Published
- 2013
- Full Text
- View/download PDF
192. How well do members of the public deal with a distributive justice problem in health care?
- Author
-
Julie Ratcliffe, Stephen Wilmot, and Clare Allen
- Subjects
Male ,Waiting Lists ,MEDLINE ,Transplants ,Social class ,Public opinion ,Resource Allocation ,Social Justice ,Health care ,Humans ,Sociology ,Distributive justice ,Aged ,Health Care Rationing ,business.industry ,Health Policy ,Patient Selection ,Public Health, Environmental and Occupational Health ,Rationing ,Public relations ,Focus Groups ,Middle Aged ,Focus group ,United Kingdom ,Liver Transplantation ,Social Class ,Public Opinion ,Resource allocation ,Female ,business ,Attitude to Health - Abstract
Objectives: There is some debate about the appropriateness of involving the general public in decisions concerning the prioritising and rationing of health care resources. Doubt has been expressed about the public's ability to deal with these issues in a fair and rational way without taking refuge in ready-made official ideologies. This study considers the quality of discussion achieved by members of the public on this issue in terms of their ability to recognise the validity of conflicting arguments, to cope with the shifting positions created by these conflicts, and to avoid opting for simplistic ready-made solutions. It also records the participants' own perceptions of the quality of their discussion. Methods: Four focus groups were recruited through community organisations in a suburban area of Derby, and were asked to evaluate criteria for the rationing of donor livers for transplantation, relating this to specific patient profiles. Discussions were recorded, transcribed and analysed using qualitative methods. Results: Three groups showed an ability to work with shifting and conflicting arguments on most issues they discussed, but two of these groups showed a tendency to adopt simplistic solutions on one specific issue. The fourth group adopted a clear-cut solution to the main issues early on, and adhered to it for the rest of the discussion. Conclusion: The overall performance of the groups suggests that rational and open public discussion can be achieved, but that participants may need support in avoiding premature adoption of simplistic solutions.
- Published
- 2004
193. LEAPing on with language: An on-line language programme to support classroom teachers and parents of primary school children (aged 5–11 years)
- Author
-
Clare Allen, M, primary, Kendrick, Andrew, additional, Archbold, Sue, additional, and Harrigan, Suzanne, additional
- Published
- 2014
- Full Text
- View/download PDF
194. MP-13.03 Does Repeat Focal Ablation using High Intensity Focused Ultrasound (Sonablate 500) Compromise Morbidity or Genito-Urinary Functional Outcome in Men with Localized Prostate Cancer?
- Author
-
Mark Emberton, Louise Dickinson, Alex Freeman, Clare Allen, Hashim U. Ahmed, Richard Hindley, and Caroline M. Moore
- Subjects
medicine.medical_specialty ,Prostate cancer ,business.industry ,Urology ,Urinary system ,medicine.medical_treatment ,medicine ,Radiology ,Focal ablation ,business ,medicine.disease ,High-intensity focused ultrasound ,Surgery - Published
- 2011
- Full Text
- View/download PDF
195. 225 FOCAL SALVAGE THERAPY COMPARED TO WHOLE-GLAND SALVAGE: A FEASIBILITY STUDY
- Author
-
Hashim U. Ahmed, Neil McCartan, Clare Allen, A. Freeman, M. Emberton, Alex Kirkham, and Paul Cathcart
- Subjects
medicine.medical_specialty ,business.industry ,Urology ,Medicine ,Salvage therapy ,business ,Surgery - Published
- 2011
- Full Text
- View/download PDF
196. 133 A NEGATIVE MULTI-PARAMETRIC MRI CAN RULE OUT UP TO 97% OF CLINICALLY SIGNIFICANT PROSTATE CANCER
- Author
-
Alex Kirkham, Mark Emberton, Hashim U. Ahmed, Nimalan Arumainayagam, Caroline M. Moore, Clare Allen, Alex Freeman, and Aslam Sohaib
- Subjects
Oncology ,PCA3 ,medicine.medical_specialty ,Prostate cancer ,Multi parametric ,business.industry ,Urology ,Internal medicine ,Medicine ,Cancer ,business ,medicine.disease - Published
- 2011
- Full Text
- View/download PDF
197. PE38: Introduction of a 'dedicated prostate surgical planning meeting' increases the frequency of nerve-sparing in men undergoing robotic prostatectomy for prostate cancer while maintaining oncological safety
- Author
-
J. Kelly, Senthil Nathan, John Hines, Tim Briggs, Clare Allen, Ashwin Sridhar, G. Basnett, Alex Kirkham, Navin Ramachandran, M. Goldstraw, Paul Cathcart, and Miles Walkden
- Subjects
medicine.medical_specialty ,Prostate cancer ,Nerve sparing ,medicine.anatomical_structure ,business.industry ,Prostate ,Urology ,Medicine ,business ,Robotic prostatectomy ,medicine.disease ,Surgical planning - Published
- 2014
- Full Text
- View/download PDF
198. 361 A pilot study assessing the toxicity profile of irreversible electroporation in the focal treatment of prostate cancer
- Author
-
Louise Dickinson, Phillip D. Stricker, Hashim U. Ahmed, M. Valerio, M. Emberton, Clare Allen, and L. Ponsky
- Subjects
Oncology ,medicine.medical_specialty ,Prostate cancer ,Focal treatment ,business.industry ,Urology ,Internal medicine ,medicine ,Irreversible electroporation ,business ,medicine.disease ,Toxicity profile - Published
- 2014
- Full Text
- View/download PDF
199. Trypanosoma cruzi: mucin pseudogenes organized in a tandem array
- Author
-
John M. Kelly and Clare Allen
- Subjects
Genetics ,Tandem ,biology ,Pseudogene ,Trypanosoma cruzi ,Immunology ,Mucin ,Molecular Sequence Data ,Restriction Mapping ,Mucins ,Kinetoplastida ,Retrotransposon ,General Medicine ,biology.organism_classification ,Blotting, Southern ,Infectious Diseases ,Restriction map ,Tandem Repeat Sequences ,parasitic diseases ,Animals ,Parasitology ,Amino Acid Sequence ,Peptide sequence ,Pseudogenes - Abstract
Allen, C.L., and Kelly, J.M. 2001. Trypanosoma cruzi: Mucin pseudogenes organized in a tandem array. Experimental Parasitology97, 173–177.
- Published
- 2001
200. Light Density Index (LDI) is a Predictor of MRI and Biopsy Outcome for WST-11 (Tookad Soluble™) Mediated Vascular Targeted Photodynamic Therapy (VTP) in Focal Treatment of Localised Prostate Cancer
- Author
-
Clare Allen, Mark Emberton, S.H. Quoraishi, L. Abenhaim, and Caroline M. Moore
- Subjects
medicine.medical_specialty ,Pathology ,medicine.diagnostic_test ,business.industry ,Urology ,medicine.medical_treatment ,Photodynamic therapy ,medicine.disease ,Prostate cancer ,Focal treatment ,Biopsy ,medicine ,Surgery ,Radiology ,business - Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.